A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis - Wikidata - awgldk - TriplyDB

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

http://www.wikidata.org/entity/Q35158547

about

Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy Multimodality imaging of Alzheimer disease and other neurodegenerative dementias Correlation between two methods of florbetapir PET quantitative analysis.Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.Multi-Kernel Learning with Dartel Improves Combined MRI-PET Classification of Alzheimer's Disease in AIBL Data: Group and Individual Analyses.Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.The emerging role of PET imaging in dementia.Centiloid method evaluation for amyloid PET of subcortical vascular dementia.Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.Modulation of glucose metabolism and metabolic connectivity by β-amyloid.Histogram-Based Features Selection and Volume of Interest Ranking for Brain PET Image Classification.

P2860

Q26382049-AEC90A77-15D7-4763-9257-C94E543993FB Q30870819-35C10B5B-6E5D-4680-86E1-553436F17352 Q33905494-0E14F0B5-BB29-4785-9DED-8B9F3095845C Q34477727-FC24DBC4-3E4E-471E-A9C4-4FCE5FF127CC Q36910036-50945EF6-1D94-449C-B360-72050B910F3D Q38497202-A29A75D0-6811-4403-930D-79993B10345C Q38633079-ED6EB11B-A323-4953-959D-84C195FAD65D Q38940217-58190F52-1F76-4B66-9658-FB8D3D3631DB Q42701971-97D45420-B881-471F-934D-F465513D4EDD Q46067045-BD83E030-D6AA-414C-8606-503396498566 Q46678949-29461DFF-DD25-4353-B187-E85FD364C31F Q47553874-92D28781-781D-47EC-B972-0B658802050D Q51209165-07CF7C31-65AA-4E8D-93BE-D1E122095650 Q51703164-15D16E48-82B1-4F67-A563-F16EEDF3F924 Q52595017-CE193B2B-4446-429A-A136-8742A178E5B4

P2860

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

http://www.wikidata.org/entity/Q35158547

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@ast

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@en

type

label

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@ast

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@en

prefLabel

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@ast

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@en

P1433

Q35158547-EF636D1F-C294-49A0-8FBD-E33E7E178B79

P1476

Q35158547-7185D662-3340-422C-B006-BD52891BE742

P2093

Q35158547-1E1A79B1-2C83-4F1B-AF5E-388288212C05

Q35158547-3419DBA9-7F30-4109-85F2-9880581E6385

Q35158547-3A1C04D9-6E32-4EFA-B96A-3097EFCE74D8

Q35158547-4A3E6B43-ABBC-4AED-AFE3-8BE73C88398B

Q35158547-758DCAE2-70BA-4FAD-911E-CC7D75F23BF6

Q35158547-BF33816F-3C8B-4E8D-8A5B-575D742BA7F1

Q35158547-F808D5E9-5434-4A26-996C-A19CF6EEF9C5

P275

Q35158547-0E32168B-4A2B-4878-9BDD-1FB54FB99C12

P2860

Q35158547-00FF557D-69F3-4726-9453-77B16707ECF0

Q35158547-0811D803-FCC4-43B1-9AFD-EBC219AD6F48

Q35158547-0A72EE66-25F4-45ED-A64E-AFD4A1CEA378

Q35158547-0E086EAC-099D-472B-A6F2-351FCEE2DF29

Q35158547-0E1C9942-E966-4C74-A793-ED0CC30512A9

Q35158547-0E58E0A7-3C6D-4065-8955-1BF1C1EC42D2

Q35158547-1157D065-9630-40C4-8752-C18BA0D31070

Q35158547-128897CC-D302-4864-850B-E9AD9AB1E10A

Q35158547-1B3A6C5E-0C8D-403F-B190-6323506A79A2

Q35158547-1BFFA110-C914-452F-9CED-EB11428C29AA

P304

Q35158547-A1FC24CC-A1A2-4FB4-9819-C71467334296

P31

Q35158547-4D38A753-AAF1-4538-9850-6369DE8D2810

Q35158547-F34AE673-CA05-40B6-97D9-3145FD414DE2

P356

Q35158547-6EDE7A70-3AA0-43E5-AECE-58EF6BDC7A7B

P407

Q35158547-055C79E1-241A-4D90-8312-D39258FADE42

P478

Q35158547-6A92982A-55A5-48F5-935C-5640A737008D

P50

Q35158547-430BFF7B-8923-4AED-B2A8-011DBD263906

P5008

Q35158547-B39D3BEC-F664-4511-A92C-C2179DF2FE5A

P577

Q35158547-7D141D6D-75C4-411D-9D43-B68325556CBF

P5875

Q35158547-BECED723-0EED-42CA-B528-E01E0F997A27

P698

Q35158547-9DC456FA-7D32-4C0B-98B6-F8E40CD7EC2A

P921

Q35158547-2BB5670B-8BE7-4417-A5FB-6017EA4E367D

Q35158547-368207FC-8886-411E-9B79-29BBD7709C66

Q35158547-79384995-1D3D-431D-809D-CC6C7B8D9739

Q35158547-7B0F0B59-931B-465F-A204-FFB60B0BA8F1

P932

Q35158547-5AC2EB5C-5DBC-4B08-A6DA-85869F6DD7B0

P356

P1433

BioMed Research International

P1476

A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis

@en

P2093

Alessandro Padovani

http://www.w3.org/2001/XMLSchema#string

Daniela Perani

http://www.w3.org/2001/XMLSchema#string

Flavio Mariano Nobili

http://www.w3.org/2001/XMLSchema#string

Giovanni Frisoni

http://www.w3.org/2001/XMLSchema#string

Leonardo Iaccarino

http://www.w3.org/2001/XMLSchema#string

Orazio Schillaci

http://www.w3.org/2001/XMLSchema#string

Pasquale Anthony Della Rosa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature

Mild cognitive impairment: clinical characterization and outcome

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Clinical amyloid imaging in Alzheimer's disease.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

P304

785039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/785039

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Caltagirone

P5008

P577

2014-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261923554

http://www.w3.org/2001/XMLSchema#string

P698

24772437

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Angliavandeniai

mechanism of action

macromolecular substances

P932

3977528

http://www.w3.org/2001/XMLSchema#string